Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Asparagine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 known ✓ | P39086 | 7/20 | 0.52 |
| ▸ | GRIK2 known ✓ | Q13002 | 4/20 | 0.52 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.48 |
| ▸ | GRIA4 known ✓ | P48058 | 4/20 | 0.45 |
| ▸ | GRIK3 known ✓ | Q13003 | 4/20 | 0.45 |
| ▸ | GRIK5 known ✓ | Q16478 | 4/20 | 0.45 |
| ▸ | GRIA2 known ✓ | P42262 | 3/20 | 0.44 |
| ▸ | GRIA1 known ✓ | P42261 | 2/20 | 0.44 |
| ▸ | GRIA3 known ✓ | P42263 | 1/20 | 0.44 |
| ▸ | GRIN2A known ✓ | Q12879 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.52 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.48 |
| ▸ | GGT1 | P19440 | 4/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asparagine SCHEMBL28655930 | 1.00 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL29449905 | 1.00 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL656714 | 1.00 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL28655929 | 1.00 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL8103410 | 1.00 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL656713 | 1.00 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL50254 | 1.00 | ALOX15 (0.54) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL28196111 | 0.97 | ALOX15 (0.52) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL31634581 | 0.97 | ALOX15 (0.52) | ALOX15BLMPMP22KMT2AGRIK1 | |
| Asparagine SCHEMBL150535 | 0.97 | ALOX15 (0.56) | ALOX15BLMPMP22KMT2AGRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2012 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122012373-A | CHO-K1 cell chemistry limiting basic culture medium | 华北制药集团新药研究开发有限责任公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4017496-B1 | FORMULATIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF PERIPHERAL NEUROPATHY AND ITS ASSOCIATED DISEASES | LOH YIN SZE (SG) | 2026-01-07 | — | — | EP | claimed |
| US-12359164-B2 | Process for producing cell culture media | MERCK PATENT GMBH (DE) | 2025-07-15 | — | — | US | claimed |
| CN-120005806-A | CHO cell culture medium and application thereof | 江苏埃美益生物技术有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119307441-B | Culture solution of bovine cloned embryo and application thereof | 内蒙古大学 | 2025-03-21 | — | — | CN | claimed |
| CN-119307441-A | Culture solution of bovine cloned embryo and application thereof | 内蒙古大学 | 2025-01-14 | — | — | CN | claimed |
| CN-119265134-A | System, method and organoid suitable for organ/organoid circulatory culture | 苏州先觉生物科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119020257-A | Perfusion culture medium for mammalian CHO cells and application thereof | 信达生物制药(苏州)有限公司 | 2024-11-26 | — | — | CN | claimed |
| EP-4455263-A1 | COMPOSITION FOR CULTURING ANIMAL CELLS | AJINOMOTO CO., INC. (JP) | 2024-10-30 | — | — | EP | claimed |
| EP-3192368-B1 | COMPOSITION FOR PRESERVING CELLS, CONTAINING, AS ACTIVE INGREDIENTS, PLANT-DERIVED RECOMBINANT HUMAN SERUM ALBUMIN AND PLANT PEPTIDES | CEFO CO LTD (KR) | 2024-10-30 | — | — | EP | claimed |
| EP-0994657-B1 | PALATABLE ELEMENTAL MEDICAL FOOD | ABBOTT LAB (US) | 2004-01-28 | — | — | EP | claimed |
| US-6245803-B1 | ENTERAL ADMINISTERING NUTRIENTS | ABBOTT LABORATORIES | 2001-06-12 | — | — | US | claimed |
| EP-0780469-B1 | Immortalized human skin cell lines and serum-free medium for the production thereof | NESTLE SA (CH) | 2001-02-28 | — | — | EP | claimed |
| EP-1059352-A1 | Long term cell culture of human carcinoma | Oncodia AG (CH) | 2000-12-13 | — | — | EP | claimed |
| EP-0994657-A1 | PALATABLE ELEMENTAL MEDICAL FOOD | Abbott Laboratories (US) | 2000-04-26 | — | — | EP | claimed |
| US-5922766-A | NUTRITIONALLY COMPLETE FOR HUMANS WITH SPECIALIZED DIETARY NEEDS, USES SPECIFIC FREE AMINO ACIDS TO PROVIDE THE SOUCE OF AMINO NITROGEN(PROTEIN EQUIVALENTS) AND SPECIAL BLENDS OF FATS THAT PROVIDE PLEASANT TASTING FORMULA WITH CALORIES | ABBOTT LABORATORIES | 1999-07-13 | — | — | US | claimed |
| WO-1999001044-A1 | PALATABLE ELEMENTAL MEDICAL FOOD | ABBOTT LABORATORIES (US) | 1999-01-14 | — | — | WO | claimed |
| WO-1995012664-A1 | ADAPTION OF MAMMALIAN CELL LINES TO HIGH CELL DENSITIES | GENETICS INSTITUTE, INC. (US) | 1995-05-11 | — | — | WO | claimed |
| US-5326908-A | Process for the preparation of asparagine | NSC TECHNOLOGIES LLC | 1994-07-05 | — | — | US | claimed |
| EP-0162422-A2 | The novel physiologically active substance foroxymithine, a process and microorganisms for its production and its use as medicament | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1985-11-27 | — | — | EP | claimed |